Pharmaceuticals: Merck Sustaining Long-term Advantage Through Information Technology Hiroshi Amari Working Paper No. 161 Working Paper Series Center on Japanese Economy and Business Columbia Business School December 1998 Columbia-Yale Project: Use of Software to Achieve Competitive Advantage PHARMACEUTICALS: MERCK Sustaining Long-term Advantage Through Information Technology Prepared by Hiroshi Amari Research Associate‚ Yale University William V. Rapp and Hugh T. Patrick Co-principal
Premium Clinical trial Pharmaceutical industry Drug development
c. Moody’s Investors Service downgraded the long-term senior unsecured rating of AZN from A1 to Aa2 in 2007. Assess any potential association between this downgrade and AZN’s arrangements with Merck. Paris‚ July 30‚ 2007 -- Moody’s Investors Service downgraded the long-term senior unsecured ratings of AstraZeneca plc and its guaranteed subsidiary to A1 from Aa2. This downgrade followed the announcement of AstraZeneca’s acquisition of MedImmune for a total consideration of more than US$15 billion
Premium Money
Business and Professional Ethics MERCK AND THE MARKETING OF VIOXX – CASE ANALYSIS Questions 1) What are the highlights of the case? 2) What are the ethical issues in the case? 3) What the ethical theories evidenced in the case? 4) How would you resolve the problem? What are the ethical issues in the case? In identifying the issue(s) we first have to identify the level in which this business is operating. Merck & Company was a top‚ well respected pharmaceutical company in America
Premium Ethics
Color blindness or color vision deficiency is the inability or decreased ability to see color‚ or distinguish color differences‚ under normal lighting conditions. Color blindness affects many people in a population. "Color blind" is a term of art; there is no actual blindness but there is a fault in the development of one or more sets of retinal cones that perceive color in light and transmit that inform ation to the optic nerve. Symptoms like those of color blindness can also be produced by physical
Premium Color
INATTENTIONAL BLINDNESS Inattentional blindness‚ also known as perceptual blindness‚ is the phenomenon of not being able to see things that are actually there. This can be a result of having no internal frame of reference to perceive the unseen objects‚ or it can be the result of the mental focus or attention which cause mental distractions. The phenomenon is due to how our minds see and process information. Closely related to the subject of change blindness‚ it is an observed phenomenon of the
Premium Inattentional blindness Blindness Attention
Symbol of Blindness in King Lear Blindness is usually defined as the physical ability of the eye to see. But in King Lear by William Shakespeare‚ blindness is not just a physical quality but also a mental flaw that people possess. This mental flaw can then lead to people making bad decisions because they can’t see the truth. In King Lear‚ the recurring images of sight and blindness that are associated with the characters of Lear and Gloucester illustrate the theme of self-knowledge and consciousness
Premium William Shakespeare King Lear Blindness
Merck was at the top of the pharmaceutical market for many years. The company made substantial profits almost every year. Not only were they a company that made money but they also made their financial gains in an ethical manor. Fourton magazine even named them the “most admired” company. But in 2004‚ the company would be faced with major challenges that would threaten to end the company’s existence. Their once best selling painkiller Viol had been recalled by the federal government because the drug
Premium Pharmacology Pharmaceutical industry
Color Blindness: Explanation Of Disease: · Color blindness is often the result of a genetic deficiency‚ but can also result from eye‚ nerve or brain damage‚ or exposure to certain chemicals. Being color blind means individuals have an inability to distinguish between some of the colors that others can see differently. Color blindness can be present from birth‚ or it may develop at a later stage in life. It can also be stationary or progressive. Normal color vision requires the use of specialized
Premium Color
Questions for the Merck Case Create a decision tree for Merck. The 2 leftmost branches would identify the alternatives related to licensing Davarink (specifically license versus not to license). Next‚ if Merck decides to pursue license‚ they go into phase I which results in a success‚ or failure. Phase I success is followed by phase II where Merck has the opportunity to develop the drug to treat depression alone‚ weight loss alone‚ or both‚ or contemplate phase II failure. Finally phase
Premium Decision tree Decision theory
Colour blindness is a very well known deficiency that affects approximately 8% of the population worldwide (Fluck 2006). People who are colour blind are not technically blind‚ they have a decreased ability to identify colours and in the most extreme cases‚ not able to see colours at all. The technical term for being colour blind is achromatopsia which means the inability to see any colours at all. However‚ most people are only colour deficient and not fully color blind therefore they can be classified
Premium Color Retina